| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5647514 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 15 Pages |
Abstract
In patients with well-controlled asthma, a change from FP/SAL to FP/FOR did not compromise asthma control. Step-down of FP/FOR was well tolerated; however, in contrast to current guidelines, our data suggest caution in stepping down patients uncontrolled in the last 12 months. Larger step-down studies are required to confirm these findings.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Omar S. MBBS, PhD, Anu PhD, Elizabeth MSc, Vicky MSc, Priyanka Raju MSc, Christina MSc, Andrew MSc, Vanessa PhD, Adam BSc, Elizabeth F. MCSP, MSc, Peter J. MA, DM, DSc, David FRCGP,